DNA Analytics — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

DNA Analytics is a private, pre-revenue biotechnology tools company founded in 2015, offering a proprietary AI-driven platform to optimize gene probe design. Its patent-pending AccuMatch™ algorithms claim significant improvements in predicting probe-target binding strength, a critical parameter for the success of CRISPR, siRNA, and antisense therapies, as well as diagnostic assays. The company operates as a B2B platform provider, offering its technology via software code, APIs, and custom pipeline development to accelerate R&D for pharmaceutical and biotech partners. Its primary value proposition is reducing development time and cost for next-generation genetic medicines by improving first-time design accuracy.

CancerNeurological DiseasesHepatological DiseasesRetinal DiseasesRare Genetic Disorders

Technology Platform

AccuMatch™: A patent-pending AI and statistical algorithm platform that predicts the melting temperature (binding strength) of chemically modified gene probes (e.g., for CRISPR, siRNA, antisense) to their DNA/RNA targets. It models the effects of modifications like LNAs to improve design accuracy.

Opportunities

The rapid growth in gene therapy, CRISPR, and oligonucleotide therapeutics creates massive demand for improved R&D tools.

DNA Analytics can capitalize by becoming a standard, embedded software for probe design, enabling faster, cheaper development for partners and capturing value through licensing and service fees.

Risk Factors

Key risks include the need for extensive third-party validation of its performance claims, competition from established and free bioinformatics tools, and the challenge of displacing entrenched workflows.

Its narrow focus on melting temperature prediction may also limit its appeal compared to integrated design suites.

Competitive Landscape

Competitors include established oligonucleotide design tools from Integrated DNA Technologies (IDT), Thermo Fisher Scientific, and other bioinformatics software providers, as well as academic algorithms. DNA Analytics differentiates by claiming a step-change improvement in the accuracy of a single, critical parameter (Tm) for chemically modified probes.

More companies in United States →